FDA OKs New Blood Cancer Drug

Friday, 08 Feb 2013 05:22 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
The Food and Drug Administration said Friday it approved a new drug from Celgene for patients with hard-to-treat multiple myeloma, a cancer of the blood.

The agency approved the pill Pomalyst for cases of the disease that have spread even after treatment with two other cancer drugs.

Multiple myeloma mainly affects older adults and kills about 10,700 people annually, according to the National Cancer Institute.

FDA noted that Pomalyst is the second drug approved for multiple myeloma in the past year. The agency approved Kyprolis from Onyx Pharmaceuticals Inc. in July 2012.

"Treatment for multiple myeloma is tailored to meet individual patient's needs, and today's approval provides an additional treatment option for patients who have not responded to other drugs," said Dr. Richard Pazdur, FDA's office director for cancer drugs, in a statement.

Obamacare: Massive New Rules Revealed for 2013

Pomalyst carries a boxed warning, the most serious type, alerting patients and doctors that the drug can cause severe birth defects in pregnant women and can cause blood clots.

Shares of Celgene Corp., based in Summit, N.J., rose $2.29, or 2.4 percent, to $100.13. The stock added 17 cents to $100.30 in after-hours trading.

© Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Ebola Treatment Strategy: Keep Patients Alive as Body Fights Back

Monday, 20 Oct 2014 17:08 PM

People who shared an apartment with the country's first Ebola patient are emerging from quarantine healthy. And while Th . . .

Goodbye to Reading Glasses?

Monday, 20 Oct 2014 16:23 PM

A new implantable eye device might make reading glasses a thing of the past, researchers report.
Many people over a . . .

Herceptin Boosts Breast Cancer Survival: Mayo Clinic

Monday, 20 Oct 2014 16:18 PM

Adding the drug Herceptin to chemotherapy for certain breast cancer patients increases overall survival and reduces the  . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved